Skip to main content
. 2023 Nov 21;14:1269605. doi: 10.3389/fphar.2023.1269605

TABLE 6.

Hormonal descriptive statistics, expressed as mean ± standard error, of participants in the two groups, berberine (B; n = 51) and control (C; n = 55), at enrolment and after 90 days of treatment.

Group/Parameter Baseline After 90 days p*
B/AMH (ng/mL) 5.00 ± 0.39 5.16 ± 0.39 n. s
C/AMH (ng/mL) 4.80 ± 0.37 4.07 ± 0.37 n. s
B/Free-T (ng/dL) 7.25 ± 2.09 5.55 ± 2.09 n. s
C/Free-T (ng/dL) 5.99 ± 2.01 5.76 ± 2.01 n. s
B/FSH (UI/L) 6.78 ± 1.36 6.09 ± 1.35 n. s
C/FSH (UI/L) 7.13 ± 1.31 9.93 ± 1.31 n. s
B/LH (UI/L) 9.88 ± 1.33 10.87 ± 1.33 n. s
C/LH (UI/L) 15.31 ± 1.28 14.37 ± 1.28 n. s

Statistics calculated as a comparison between “baseline” and between “after 90 days” values demonstrated not significant differences. *statistics calculated as “after 90 days” versus “baseline. AMH, Anti-Mullerian Hormone; T, testosterone; FSH, Follicle-Stimulating Hormone; LH, luteinizing hormone; n. s., not significant.